M D Althuis

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Glucose and insulin responses to dietary chromium supplements: a meta-analysis
    Michelle D Althuis
    Statistics Collaborative, Inc, Washington, DC, USA
    Am J Clin Nutr 76:148-55. 2002
  2. pmc Hormonal content and potency of oral contraceptives and breast cancer risk among young women
    M D Althuis
    Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 7084, EPS MSC 7234, Rockville, MD 20852 USA
    Br J Cancer 88:50-7. 2003
  3. ncbi request reprint Breast cancers among very young premenopausal women (United States)
    Michelle D Althuis
    National Cancer Institute, Rockville, MD, USA
    Cancer Causes Control 14:151-60. 2003
  4. ncbi request reprint Uterine cancer after use of clomiphene citrate to induce ovulation
    Michelle D Althuis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7234, USA
    Am J Epidemiol 161:607-15. 2005
  5. ncbi request reprint Ovarian cancer risk associated with varying causes of infertility
    Louise A Brinton
    Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Bethesda, MD 20852, USA
    Fertil Steril 82:405-14. 2004
  6. ncbi request reprint Breast cancer risk associated with ovulation-stimulating drugs
    Louise A Brinton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Hum Reprod 19:2005-13. 2004
  7. ncbi request reprint Ovarian cancer risk after the use of ovulation-stimulating drugs
    Louise A Brinton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7068, Bethesda, MD 20852 7234, USA
    Obstet Gynecol 103:1194-203. 2004
  8. ncbi request reprint Is male breast cancer similar or different than female breast cancer?
    William F Anderson
    NCI Division of Cancer Prevention, Bethesda, MD 20892 7317, USA
    Breast Cancer Res Treat 83:77-86. 2004
  9. ncbi request reprint Causes of infertility as predictors of subsequent cancer risk
    Louise A Brinton
    National Cancer Institute, Rockville, Maryland 20852 7234, USA
    Epidemiology 16:500-7. 2005
  10. ncbi request reprint Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs
    Michelle D Althuis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Am J Obstet Gynecol 193:668-74. 2005

Detail Information

Publications14

  1. ncbi request reprint Glucose and insulin responses to dietary chromium supplements: a meta-analysis
    Michelle D Althuis
    Statistics Collaborative, Inc, Washington, DC, USA
    Am J Clin Nutr 76:148-55. 2002
    ....
  2. pmc Hormonal content and potency of oral contraceptives and breast cancer risk among young women
    M D Althuis
    Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 7084, EPS MSC 7234, Rockville, MD 20852 USA
    Br J Cancer 88:50-7. 2003
    ..Our findings suggest that newer low-potency/low oestrogen dose oral contraceptives may impart a lower risk of breast cancer than that associated with earlier high-potency/high-dose preparations...
  3. ncbi request reprint Breast cancers among very young premenopausal women (United States)
    Michelle D Althuis
    National Cancer Institute, Rockville, MD, USA
    Cancer Causes Control 14:151-60. 2003
    ..To assess risk factors for breast cancer among very young compared to older premenopausal women...
  4. ncbi request reprint Uterine cancer after use of clomiphene citrate to induce ovulation
    Michelle D Althuis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7234, USA
    Am J Epidemiol 161:607-15. 2005
    ..52, 95% CI: 1.5, 108.0). Clomiphene may increase uterine cancer risk, with higher doses leading to higher risk. Long-term follow-up of infertility cohorts is necessary to clarify the association between clomiphene use and uterine cancer...
  5. ncbi request reprint Ovarian cancer risk associated with varying causes of infertility
    Louise A Brinton
    Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Bethesda, MD 20852, USA
    Fertil Steril 82:405-14. 2004
    ..To evaluate the risk of ovarian cancer as related to underlying causes of infertility...
  6. ncbi request reprint Breast cancer risk associated with ovulation-stimulating drugs
    Louise A Brinton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Hum Reprod 19:2005-13. 2004
    ..Despite the recognized role of hormones in the aetiology of breast cancer, there has been little evaluation of hormonal preparations used to treat infertility...
  7. ncbi request reprint Ovarian cancer risk after the use of ovulation-stimulating drugs
    Louise A Brinton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7068, Bethesda, MD 20852 7234, USA
    Obstet Gynecol 103:1194-203. 2004
    ..To assess the long-term effects of ovulation-stimulating drugs on the risk of ovarian cancer...
  8. ncbi request reprint Is male breast cancer similar or different than female breast cancer?
    William F Anderson
    NCI Division of Cancer Prevention, Bethesda, MD 20892 7317, USA
    Breast Cancer Res Treat 83:77-86. 2004
    ..To determine if male breast carcinogenesis was similar to its more common female counterpart, we compared incidence patterns among men and women with breast cancer...
  9. ncbi request reprint Causes of infertility as predictors of subsequent cancer risk
    Louise A Brinton
    National Cancer Institute, Rockville, Maryland 20852 7234, USA
    Epidemiology 16:500-7. 2005
    ..Although studies have found elevated risks of certain cancers linked to infertility, the underlying reasons remain unclear...
  10. ncbi request reprint Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs
    Michelle D Althuis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Am J Obstet Gynecol 193:668-74. 2005
    ..This study was undertaken to evaluate melanoma, thyroid, colon, and cervical cancer risks after clomiphene or gonadotropins...
  11. ncbi request reprint Global trends in breast cancer incidence and mortality 1973-1997
    Michelle D Althuis
    Hormone and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS MSC 7234, Rockville, MD 20852, USA
    Int J Epidemiol 34:405-12. 2005
    ..Worldwide, breast cancer is the most common cancer and is the leading cause of cancer death among women...
  12. ncbi request reprint Etiology of hormone receptor-defined breast cancer: a systematic review of the literature
    Michelle D Althuis
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Room 7084, 6120 Executive Boulevard, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 13:1558-68. 2004
    ..Large population-based studies of determinants of hormone receptor-defined breast cancers defined using state-of-the-art quantitative immunostaining methods are needed to clarify the role of ER/PR expression in breast cancer etiology...
  13. pmc Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China
    Gabriella Andreotti
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
    Int J Cancer 122:2322-9. 2008
    ..Our findings support a role for serum lipids in gallstone development and biliary carcinogenesis...
  14. ncbi request reprint Oral contraceptives and the risk of breast cancer
    Michelle D Althuis
    N Engl J Med 347:1448-9; author reply 1448-9. 2002